Zolinza (Vorinostat) – CTCL | HongKong DengYue Medicine
- Generic Name/Brand Name: Vorinostat / Zolinza®
- Indications: CTCL
- Dosage Form: Capsule
- Specification: 100 mg × 120 capsules/bottle
Vorinostat Application Scope
Zolinza is an oral histone deacetylase (HDAC) inhibitor that induces cell cycle arrest, differentiation, and apoptosis in malignant cells by altering gene expression.
Indications:
-
Cutaneous T-cell lymphoma (CTCL): For patients with progressive, persistent, or recurrent disease following at least two systemic therapies.

Vorinostat Characteristics
-
Ingredients: Active ingredient: Vorinostat
Excipients: microcrystalline cellulose, magnesium stearate, sodium starch glycolate, etc. -
Properties: White to off-white capsules.
-
Packaging Specification: 100 mg capsules, bottles of 120.
-
Storage: Store at 20–25°C. Protect from moisture.
-
Expiry Date: As indicated on package (24–36 months).
-
Executive Standard: Enterprise/regulatory authority standard.
-
Approval Number: Per FDA/NMPA/EMA records.
-
Date of Revision: As listed in insert.
-
Manufacturer: Merck & Co., Inc.
Guidelines for the Use of Zolinza
-
Dosage and Administration:
-
Recommended Dose: 400 mg orally once daily.
-
Administration: Swallow whole with food.
-
Missed Dose: Skip and take the next scheduled dose. Do not double dose.
-
-
Adverse Reactions:
-
Common Adverse Reactions:
-
Fatigue
-
Nausea, diarrhea, anorexia
-
Thrombocytopenia, anemia
-
Weight loss
-
-
Serious Adverse Reactions:
-
Pulmonary embolism, deep vein thrombosis
-
Severe thrombocytopenia or anemia
-
QT prolongation, cardiac events
-
Severe dehydration from GI toxicity
-
-
-
Contraindications:
-
Hypersensitivity to Vorinostat or excipients.
-
Pregnancy and breastfeeding.
-
-
Precautions:
-
Monitor CBC, electrolytes, ECG.
-
Use caution in patients with prior thromboembolic disease.
-
Ensure adequate hydration.
-
Vorinostat Interactions
-
Caution with anticoagulants (↑ bleeding risk).
-
May interact with other HDAC inhibitors (↑ toxicity).
-
CYP substrate interactions possible.
Note:
- If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
- This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.









.webp)
Reviews
There are no reviews yet.